Budget IMPACT Analysis of a Reduced Maintenance Dose of Certolizumab Pegol in Patients with Axial Spondyloarthritis in the United Kingdom |
Author(s): Kiri S, Arteaga Duarte C, Lamotte M, Gerlier L
|
Affiliations(s): IQVIA HEOR Zaventem
|
Publication(s): ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 107821
|
Document Type(s): Poster, |
Countries: USA, |
C: Y: |
Rheumatology, 2020 |
|
L: A: |
English clinical setting: Secondary care, Cost effectiveness, |
|
|
|
|
Cost-Effectiveness Analysis of Certolizumab Pegol Versus Secukinumab and Ixekizumab in Non-Radiographic Axial Spondyloarthritis in the U.S |
Author(s): Kiri S, Arteaga Duarte Ca, Lee E, Low R, Tsakeu E, Lamotte M, Gerlier L.
|
Affiliations(s): IQVIA HEOR Zaventem
|
Publication(s): AMCP Nexus 2020 Virtual October 19.
|
Document Type(s): Poster, |
Countries: USA, |
C: Y: |
Rheumatology, 2020 |
|
L: A: |
English clinical setting: Secondary care, Cost effectiveness, |
|
|
|
|
Reduction in the Utilization of Prednisone or Methotrexate in Canadian Claims Data Following Initiation of Etanercept in Pediatric Patients with Juvenile Idiopathic Arthritis |
Author(s): Majed M M Khraishi1, Brad Millson2, John Woolcott3, Lisa Marshall4 and Heather Jones4 |
Affiliations(s): 1Memorial University of Newfoundland, St John's, NF, Canada, 2IQVIA, Kanata, ON, Canada, 3Global Outcomes & Evidence, Pfizer, Collegeville, PA, 4Pfizer, Collegeville, PA |
Publication(s): Annals of the Rheumatic Diseases 2018;77:494.
|
Document Type(s): Article, |
Countries: Canada, |
Click here for the abstract |
C: Y: |
Pediatrics, Rheumatology, 2019 |
|
L: A: |
English Longitudinal study, Retrospective database analysis, |
|
|
|
|
Real-world utilization of methotrexate or prednisone co-therapy with etanercept among Canadian patients with rheumatoid arthritis: a retrospective cohort study |
Author(s): Majed Khraishi, Jelena Ivanovic, Yvonne Zhang, Brad Millson, Marie-Josee Brabant, John Woolcott, Heather Jones & Cinzia Curiale |
Affiliations(s): |
Publication(s): Journal of Current Medical Research and Opinion, Accepted author version posted online: 25 Jun 2019, Published online: 10 Jul 2019
|
Document Type(s): Article, |
Countries: Canada, |
Click here for the abstract |
C: Y: |
Rheumatology, 2019 |
|
L: A: |
English Retrospective cohort analysis, |
|
|
|
|
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain. |
Author(s): Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W. |
Affiliations(s): IQVIA, Real World Evidence, London N1 9JY, UK.
Lilly Spain, Health Outcomes & RWE, Alcobendas 28108, Spain.
Lilly Spain, Medical, Alcobendas 28108, Spain.
Lilly, Global Patient Reported Outcomes and Real World Evidence (GPORWE) International, Windlesham, Surrey GU20 6PH, UK. |
Publication(s): Clinicoecon Outcomes Res. 2019 Jun 6;11:395-403
|
Document Type(s): Article, |
Countries: Spain, |
Click here for the abstract |
C: Y: |
Rheumatology, 2019 |
|
L: A: |
English Retrospective cohort analysis, |
|
|
|
|
Biological Treatment Patterns with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up |
Author(s): Cañete JD1, Naranjo A2, Calvo J3, Ordás C4, Aragón B5, Nocea G5, Roset M6, Fernández-Nebro A7 |
Affiliations(s): 1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, Spain 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, Spain 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, Spain 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, Spain 6 IQVIA, Barcelona, Spain 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain |
Publication(s): Reumatol Clin. 2019 Jan 28. pii: S1699-258X(18)30259-6
|
Document Type(s): Article, |
Countries: Spain, |
Click here for the abstract |
C: Y: |
Rheumatology, 2019 |
|
L: A: |
Spanish Population Based Study, Survey research, |
|
|
|
|
Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use |
Author(s): Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M |
Affiliations(s): IQVIA |
Publication(s): Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372
|
Document Type(s): Article, |
Countries: France, Greece, Italy, Portugal, |
Click here for the abstract |
C: Y: |
Musculoskeletal disease, Rheumatology, Risk Management & REMS, 2019 |
|
L: A: |
English Survey research, |
|
|
|
|
Two-year adherence and costs for biologic therapy for rheumatoid arthritis |
Author(s): Stolshek BS, Wade S, Mutebi A, De AP, Wade RL, Yeaw J |
Affiliations(s): Amgen, IQVIA |
Publication(s): Am J Manag Care
|
Document Type(s): Article, |
Countries: USA, |
Click here for the abstract |
C: Y: |
Rheumatology, 2018 |
|
L: A: |
English Cost analysis, Retrospective cohort analysis, |
|
|
|
|
Assessing Treatment Tolerability for Rheumatoid Arthritis. Validation and Practical Applications of the ‘TOL-AR-18 Questionnaire |
Author(s): Corominas H, Espadaler L, Gómez A, Ros I, Urruticoechea A, Sarmiento M, Sanmartí R |
Affiliations(s): Corominas H.: Rheumatology and Autoimmune diseases Division, Hospital Universitari de Sant Pau & Hospital Dos de Maig, Barcelona, Spain
Sarmiento M: Real-World Evidence Solutions, IMS Health, Spain |
Publication(s): Reumatología Clínica 2018; Sep 5. [Epub ahead of print]
|
Document Type(s): Article, |
Countries: Spain, |
Click here for the abstract |
C: Y: |
Health status & patient reported outcomes, Rheumatology, 2018 |
|
L: A: |
English Clinical setting: hospital, Observational study, |
|
|
|
|
Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients – Three-Year Results from the COMPANION Study in Rheumatology Patients |
Author(s): Bessette L1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3 |
Affiliations(s): 1 Department of Medicine, Laval University, Quebec City, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada; 3AbbVie Corporation, St. Laurent, Quebec, Canada |
Publication(s): Canadian Rheumatology Association 2017 Scientific Meeting, February 8-11, Ottawa, Canada
|
Document Type(s): Poster, |
Countries: Canada, |
Click here for the abstract |
C: Y: |
Rheumatology, 2017 |
|
L: A: |
English Database Study, |
|
|
|
|
1 of 11
|